Inhibrx Biosciences, Inc. financial data

Symbol
INBX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
11025 N. Torrey Pines Road, Suite 140, La Jolla, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.5M shares
Common Stock, Shares, Outstanding 14.5M shares
Common Stock, Value, Issued 1K USD
Weighted Average Number of Shares Outstanding, Basic 14.6M shares +34%
Weighted Average Number of Shares Outstanding, Diluted 14.8M shares +35.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 100K USD +233%
Research and Development Expense 67.6M USD +98.3%
General and Administrative Expense 93.4M USD +1186%
Operating Income (Loss) -161M USD -289%
Nonoperating Income (Expense) 2.02B USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 1.86B USD
Income Tax Expense (Benefit) 2K USD -60%
Net Income (Loss) Attributable to Parent 1.86B USD
Earnings Per Share, Basic 127 USD/shares
Earnings Per Share, Diluted 125 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 227M USD
Other Assets, Current 966K USD
Assets, Current 242M USD
Property, Plant and Equipment, Net 7.61M USD
Operating Lease, Right-of-Use Asset 2.01M USD
Other Assets, Noncurrent 6.75M USD
Assets 258M USD
Accounts Payable, Current 13M USD
Employee-related Liabilities, Current 4.51M USD
Accrued Liabilities, Current 23.9M USD
Liabilities, Current 39.1M USD
Operating Lease, Liability, Noncurrent 0 USD
Liabilities 39.1M USD
Retained Earnings (Accumulated Deficit) -14.4M USD
Stockholders' Equity Attributable to Parent 219M USD
Liabilities and Equity 258M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 120M shares
Common Stock, Shares, Issued 14.5M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 227M USD +17.9%
Operating Lease, Liability 2.17M USD
Lessee, Operating Lease, Liability, to be Paid 2.27M USD
Property, Plant and Equipment, Gross 15.1M USD
Operating Lease, Liability, Current 2.17M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.14M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 98K USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 15M shares
Additional Paid in Capital 234M USD
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 475K USD +61%
Share-based Payment Arrangement, Expense 1.8M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares